Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Class A Ordinary Shares, nominal value $0.000273235 per share
-
Shares outstanding
-
45,164,898
-
Total 13F shares
-
38,910,834
-
Share change
-
-789,194
-
Total reported value
-
$769,756,202
-
Put/Call ratio
-
103%
-
Price per share
-
$19.78
-
Number of holders
-
156
-
Value change
-
-$20,642,445
-
Number of buys
-
73
-
Number of sells
-
91
Institutional Holders of Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares, nominal value $0.000273235 per share (KNSA) as of Q4 2024
As of 31 Dec 2024,
Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares, nominal value $0.000273235 per share (KNSA) was held by
156 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
38,910,834 shares.
The largest 10 holders included
BlackRock, Inc., BRAIDWELL LP, VANGUARD GROUP INC, BAKER BROS. ADVISORS LP, Rubric Capital Management LP, Fairmount Funds Management LLC, HHLR ADVISORS, LTD., MORGAN STANLEY, Pictet Asset Management Holding SA, and Nuveen Asset Management, LLC.
This page lists
156
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.